These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14631616)

  • 21. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of recombinant factor VIIa in inherited platelet disorders.
    Kaleelrahman M; Minford A; Parapia LA
    Br J Haematol; 2004 Apr; 125(1):95-6. PubMed ID: 15015980
    [No Abstract]   [Full Text] [Related]  

  • 24. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
    Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
    Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In process].
    Koczorek M
    Med Monatsschr Pharm; 2016 Sep; 39(9):400-1. PubMed ID: 29956518
    [No Abstract]   [Full Text] [Related]  

  • 26. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
    J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S; Levy T; Budnik I; Barg AA; Rosenberg N; Seligsohn U; Kenet G; Livnat T
    Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery.
    Lison S; Spannagl M; Heindl B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):371-3. PubMed ID: 19367156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
    Yan Q; Chang AC
    Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia.
    Lombardo VT; Sottilotta G
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):115-6. PubMed ID: 16444446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
    Kogan A; Berman M; Stein M; Vidne BA; Raanani E
    J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIII/von Willebrand factor concentrate for treatment of life threatening epistaxis in Glanzmann's thrombasthenia.
    Zinke RA; Ornstein DL; Holmes CE
    Haemophilia; 2010 Jul; 16(4):701-4. PubMed ID: 20331758
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of rFVIIa in Preventing Recurrent Intra-articular Hemorrhages in a 15-Year-Old Patient With Glanzmann Thrombasthenia.
    Laguna P
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1120-e1123. PubMed ID: 33625096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of bleeding and response to therapy in Glanzmann thrombasthenia.
    Borhany M; Fatima H; Naz A; Patel H; Shamsi T
    Haemophilia; 2012 Nov; 18(6):e423-5. PubMed ID: 22970800
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies.
    Patel RK; Savidge GF; Rangarajan S
    Br J Haematol; 2001 Jul; 114(1):245-6. PubMed ID: 11472380
    [No Abstract]   [Full Text] [Related]  

  • 38. Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia.
    Humphreys I; Saraiya S; Belenky W; Dworkin J
    Ann Otol Rhinol Laryngol; 2011 Nov; 120(11):732-6. PubMed ID: 22224315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN; Saylan S; Cekic B
    Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.
    Tuffigo M; Lazaro E; James C; Subtil C; Viallard JF; Fiore M
    Haemophilia; 2015 Jan; 21(1):e116-8. PubMed ID: 25471665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.